OMEROS CORP Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-03-31: Form 10-K; Exhibit 10.33; Description Asset Purchase and License Agreement, dated as of October 10, 2025, between Omeros Corporation and Novo Nordisk Health Care AG.
- 2025-07-25: Form 8-K; Exhibit 10.2; Description Placement Agent Agreement, dated as of July 24, 2025, by and between the Company and D. Boral Capital LLC..
- 2025-07-25: Form 8-K; Exhibit 10.1; Description Securities Purchase Agreement, dated as of July 24, 2025, by and between the Company and the investor named therein..
- 2025-05-15: Form 8-K; Exhibit 10.2; Description Form of Note Conversion Agreement, dated as of May 12, 2025, among the Company and the holders named therein.*.
| Filed | Form | Exhibit | Description |
|---|
| 2026-03-31 | 10-K | 10.33 | Asset Purchase and License Agreement, dated as of October 10, 2025, between Omeros Corporation and Novo Nordisk Health Care AG |
|---|